IMRX NASDAQ
Immuneering Corporation
1W: -4.7%
1M: -18.9%
3M: -20.8%
YTD: -38.5%
1Y: -36.0%
3Y: -50.2%
5Y: -85.2%
$4.07
+0.04 (+0.99%)
Weekly Expected Move ±5.6%
$4
$4
$4
$4
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
7 relationships7
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2025-09-24
Earliest Filing
2025-09-25
Latest Filing
partner: 4
investor: 3
Counterparties (Filed by IMRX)
7 relationshipsCompanies named in IMRX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Underwriter for the public offering of Class A common stock | 2025-09-25 | View |
| Oppenheimer & Co. Inc. | OPY | partner | Underwriter for the public offering of Class A common stock | 2025-09-25 | View |
| Aventis Inc. | — | investor | Investor in the private placement contingent on the public offering | 2025-09-25 | View |
| Sanofi | SNYNF | partner | Parent company of Aventis Inc., the investor in the private placement | 2025-09-25 | View |
| Piper Sandler & Co. | PIPR | partner | Partner in the at-the-market (ATM) equity distribution agreement | 2025-09-25 | View |
| Aventis Inc. | — | investor | Investor in a private placement of Class A and/or Class B common stock. | 2025-09-24 | View |
| Sanofi | SNYNF | investor | Parent company of Aventis Inc., the investor in the private placement. | 2025-09-24 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-15 | Officer/Director Change | View | |
| 2026-06-11 | Shareholder Vote | View | |
| 2026-06-01 | Other Events | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-03-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-01-07 | Other Events | View | |
| 2025-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-25 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-09-24 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-08-25 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Other Events; Fin | Agreement | View |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-17 | Other Events | View | |
| 2025-06-16 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-13 | Other Events | View | |
| 2025-01-07 | Other Events | View | |
| 2024-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-10-02 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR